Evidence map›Paper›PMID 38786093›Full record

ArticleCells2024

Retinoid Synthesis Regulation by Retinal Cells in Health and Disease.

Massimiliano Andreazzoli, Biancamaria Longoni, Debora Angeloni, Gian Carlo Demontis

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Massimiliano AndreazzoliDepartment of Biology, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-9633-204X
Biancamaria LongoniDepartment of Translational Medicine and New Technologies in Medicine, University of Pisa, 56126 Pisa, Italy.
Debora AngeloniThe Institute of Biorobotics, Scuola Superiore Sant'Anna, 56127 Pisa, Italy.
Gian Carlo DemontisDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7641-0426

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vision starts in retinal photoreceptors when specialized proteins (opsins) sense photons via their covalently bonded vitamin A derivative 11cis retinaldehyde (11cis-RAL). The reaction of non-enzymatic aldehydes with amino groups lacks specificity, and the reaction products may trigger cell damage. However, the reduced synthesis of 11cis-RAL results in photoreceptor demise and suggests the need for careful control over 11cis-RAL handling by retinal cells. This perspective focuses on retinoid(s) synthesis, their control in the adult retina, and their role during retina development. It also explores the potential importance of 9cis vitamin A derivatives in regulating retinoid synthesis and their impact on photoreceptor development and survival. Additionally, recent advancements suggesting the pivotal nature of retinoid synthesis regulation for cone cell viability are discussed.

Indexed as

RetinoidsAnimalsHumansRetinaRetinaldehydeRetinal DiseasesVitamin ARetinaldehydeRetinoidsVitamin A11cis retinaldehyde9cis retinaldehydecone photoreceptorsMüller glial cellsretinal dystrophiesretinoic acidrod photoreceptorsRPERPE65vision

Identifiers

PMID38786093
PMCPMC11120330

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.